172 Transforming the National Genomic Test Directory to Improve Genomic Testing for CNS Tumours

Abstract excerpt

Abstract Introduction The National Genomic Test Directory (NGTD), introduced in 2019, defines NHS commissioned genomic tests in England and outlines their clinical eligibility. In cancers of the central nervous system (CNS), neuropathologists routinely integrate genomic analysis into diagnostic workflows to support tumour classification and clinical patient management. However, the existing Excel based NGTD is dif...

Topics

Open a Topic to create a Post that cites this publication.

• Genomics and Rare Diseases
• Glioma Diagnosis and Treatment
• Neuroblastoma Research and Treatments

Identifiers and source

Literature Corpus work

b8811ba7-c70d-5d5a-8cd3-5c87ff3f37f9

DOI

10.1093/neuonc/noag172.045